InvestorsObserver is giving Epizyme Inc (EPZM) an Analyst Rating Rank of 57, meaning EPZM is ranked higher by analysts than 57% of stocks. The average projection by analysts for EPZM is $23.428 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With Epizyme Inc Stock Today?
Epizyme Inc (EPZM) stock is trading at $12.31 as of 1:17 PM on Wednesday, Jan 20, a rise of $0.50, or 4.23% from the previous closing price of $11.81. The stock has traded between $11.61 and $12.69 so far today. Volume today is 945,146 compared to average volume of 1,030,936.
Click Here to get the full report on Epizyme Inc (EPZM) Stock.
